FDA Adverse Event Injury Summary report: N

PELVISOFT ACELLULAR COLLAGEN BIOMESH

MDR report key: 2980554 · Received February 21, 2013

Report

Report Number
1018233-2013-00487
Event Type
Injury
Date Received
February 21, 2013
Report Date
October 29, 2015
Manufacturer
TISSUE SCIENCE LABORATORIES
Product Code
FTM
PMA / PMN Number
K031332
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATE IN THE PRECAUTIONS: "PELVISOFT BIOMESH IS FOR SINGLE-PATIENT USE ONLY AND IS TO BE IMPLANTED SURGICALLY. IF EITHER THE OUTER POLYESTER/POLYETHYLENE POUCH OR THE INNER FOIL POUCH HAS BEEN PERFORATED OR TORN IN SHIPMENT OR STORAGE, THEN THE ENCLOSED PELVISOFT BIOMESH SHOULD NOT BE USED. PELVISOFT BIOMESH SHOULD BE HYDRATED OR MOIST WHEN THE PACKAGE IS OPENED. DEHYDRATED OR DRY TISSUE SHOULD NOT BE IMPLANTED." (B)(4).

Description of Event or Problem · 1

THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADDITIONAL INFORMATION HAS BEEN REQUESTED, BUT NOT YET RECEIVED. ASSOCIATED MDR: 1018233-2013-00484, 1018233-2013-00485, 1018233-2013-00486,1018233-2013-00488, AND 1018233-2013-00489.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
75097 PELVISOFT ACELLULAR COLLAGEN BIOMESH Mesh, surgical FTM TISSUE SCIENCE LABORATORIES NA 07B02-1

Patients

Seq Age Sex Outcome Treatment
1 64 YR Female Required Intervention PELVILACE TO TRANSOBTURATOR BIOURETHRAL SUPPORT| PELVISOFT ACELLULAR COLLAGEN BIOMESH| SYSTEM| SYSTEM| PELVISOFT ACELLULAR COLLAGEN BIOMESH| PELVILACE TO TRANSOBTURATOR BIOURETHRAL SUPPORT